Real-World Use of Somatropin Confirmed Safe and Effective for Adult Growth Hormone Deficiency
Drug Use Investigation of Somatropin for GHD-ADULTS.
Study Design
Population
Adolescents with Non-Alcoholic Fatty Liver Disease (NAFLD).
Intervention
Recombinant human growth hormone (rhGH).
Outcome
Improvements in liver fat, inflammation markers, and BMI.
Abstract
This study provides promising early evidence that recombinant human growth hormone (rhGH) could be a safe and effective therapeutic option for adolescents grappling with NAFLD. The observed improvements in liver fat, inflammation markers, and BMI suggest a multi-faceted benefit that addresses several aspects of the disease pathology.
